West Pharmaceutical Services | WST - Loan Capital

Stock Price
304.08
Daily Change
1.19 0.39%
Monthly
9.38%
Yearly
39.99%
Q2 Forecast
296.80

West Pharmaceutical Services reported $202.8M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Align Technology USD 0 0 Dec/2024
Avanos Medical USD 87.3M 3M Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Cerus USD 64.86M 22K Dec/2024
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Cooper Companies USD 1.88B 578.5M Dec/2025
Dentsply International USD 2.01B 9M Mar/2026
Haemonetics USD 919.99M 406K Dec/2025
ICU Medical USD 1.26B 4.09M Mar/2026
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Neogen USD 793.3M 374K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Quidel USD 0 2.47B Mar/2026
Repligen USD 546.58M 4.37M Mar/2026
Rockwell Medical USD 8.65M 89K Jun/2025
Solventum Corp USD 4.58B 460M Mar/2026
STAAR Surgical USD 42K 42K Dec/2023
Terumo JPY 99.91B 13M Mar/2026
Utah Medical Products USD 0 0 Mar/2022
West Pharmaceutical Services USD 202.8M 0 Mar/2026